It confirms just how major an advancement the Ebola vaccine remains; the study is the first to show that in addition to preventing infections, the vaccine can save some people who are already sick ...

Ebola cases are very rare in the United States. The U.S. Food and Drug Administration has for the first time approved a vaccine for the prevention of the deadly Ebola virus disease. The agency ...

GlaxoSmithKline makes Ebola vaccine stockpiles as human trials begin. — -- The first human trial for an investigational Ebola vaccine is set to begin this week. The ongoing Ebola outbreak in ...

The first human trials of a Canadian Ebola vaccine began Monday, part of a flood of experimental therapies rushed into testing to battle the Ebola epidemic. Although the world has been fighting ...

but we now finally have a successful Ebola vaccine candidate in development. If approved, the vaccine would vastly reduce the likelihood of ever seeing another major Ebola outbreak. More than a ...

It’s official. We now have a real Ebola vaccine. Not a kind-of-almost-sort-of-there vaccine. Not an experimental-use vaccine. Not a vaccine just for macaques. No, this is a vaccine that the ...

Outbreaks of the deadly Ebola virus flare up in parts of Africa almost every year. The virus kills about half the people it infects. But a new study shows that a vaccine already in use is offering ...

It was in the aftermath of the sweeping 2014 through 2016 West African Ebola outbreak that vaccine-development studies produced the first Ebola inoculation, Ervebo, which was approved by the U.S ...

Health officials remain hopeful that an experimental Ebola vaccine will help control the outbreak sweeping the Democratic Republic of Congo in central Africa. Since April 4, 45 hemorrhagic fever ...

There were no drugs or vaccines approved to treat or prevent Ebola or ready to enter into clinical trials at the outset of the epidemic. Therefore, many felt it was ethically necessary to conduct ...

In the midst of a deadly epidemic like Ebola, who should get an experimental vaccine that provides protection against the disease 97.5% of the time? The obvious candidates would be immediate ...